MDM2 and esophageal cancer: Nine studies6, 7, 8, 9, 10, 11, 12, 13, 14 relevant to MDM2 T309G single nucleotide polymorphism and esophageal cancer susceptibility fulfilled the inclusion criteria and were included in the meta‐analysis (Fig 1).